A shuttered Milanese manufacturing site with a storied history is getting a new lease on life, thanks to a nearly half-a-billion-dollar investment from Italian drugmaker Chiesi.

Aptar Pharma Enters into Exclusive Agreement with Pulmotree to Develop and Promote Kolibri™ Non-Propellant Liquid Inhaler Platform ...

Process development is the exercise of creating new and improved manufacturing methods, optimizing them in terms of time and financial efficiency while maintaining regulatory compliance and ...

The rise of pharmaceutical continuous manufacturing (PCM), which is often supported by process analytical technology (PAT), has improved the safety, quality, efficacy, consistency, and purity of ...

The investment of over $6 million will expand LGM Pharma’s Rosenberg, Texas manufacturing facility as part of its Phase I CDMO growth strategy.

Ori Biotech has lassoed a significant milestone for its space- and cost-efficient cell and gene therapy manufacturing ...

The consortium will look to create systems equipped with automated visual inspection and in-line process and product quality monitoring, all of which will require a new generation of skilled ...

The FTC is investigating Teva Pharmaceuticals for alleged misuse of inhaler patents to block generic competition and maintain high prices in the U.S. while selling the same products for less overseas.